Current Impactful Studies
These studies will have been recently published in the last few months, and rightly or wrongly receiving media attention. Negative media attention is by its very nature, vastly more common, as 'bad news travels or sells'. Some may be described as junk studies, but we must demonstrate why that is the the case in a Scientific logical manner,not just simply dismiss. Please consult E-Cigarette Research Forum that may well have examined and assessed a study you may have an interest
2019 E-cigarettes and Primary Care. A cross-sectional survey of nurses and GPs across the UK
- Key findings
- E-cigarettes are frequently brought up in conversations between clinicians and patients who smoke
- 3 in 10 clinicians say that the topic of ecigarettes is raised in the majority of conversations about smoking.
- Beliefs: Clinicians are often unsure in their beliefs around e-cigarettes
- Over 1 in 3 clinicians are unsure if ecigarettes are safe enough to recommendas a quit tool to patients who smoke.
- 1 in 3 are unsure whether e-cigarettes areaddictive.
- Advice: Many clinicians are reluctant tosuggest e-cigarettes as a tool to quit smoking
- When asked what advice they would give patients on e-cigarettes, 3 in 5 clinicianssaid “we do not know enough about themso I don’t endorse them”.
- 2 in 5 said they would feel uncomfortable recommending e-cigarettes to theirpatients who smoke.
- 1 in 6 clinicians said they would neverrecommend using e-cigarettes topatients who smoke.
- There was no clear agreement as to whether clinicians would primarily recommend e-cigarettes as a first line or last resort therapy.
HEALTH OUTCOMES IN COPD SMOKERS USING HEATED TOBACCO PRODUCTS: A 3-YEAR FOLLOW-UP < via Ricardo Polosa et al
- This study is the first to describe the long-term health effects of HTP use in COPD patients. Consistent improvements in respiratory symptoms, exercise tolerance, quality of life, and rate of disease exacerbations were observed in patients with COPD who abstained from smoking or substantially reduced their cigarette consumption by switching to HTP use.
Characteristics and Correlates of Recent Successful Cessation Among Adult Cigarette Smokers, United States,2018
- What is already known on this topic?
- Increasing smoking cessation reduces smoking-related disease, death, and economic costs.
- What is added by this report?
- In 2018, 7.1% of US adult smokers reported recent successful quitting. However, some groups had less success, including certain demographic groups, and some groups had greater success, including exclusive e-cigarette users, people with smoke-free home rules, and people who received advice to quit from a medical doctor.
- What are the implications for public health practice?
- To help more smokers quit, public health practitioners can ensure that evidence-based tobacco control interventions, including barrier-free access to evidence-based cessation treatments, are reaching all tobacco users, especially those who face greater barriers to quitting.
Associations between vaping and Covid-19: cross-sectional findings from the HEBECO study
- Conclusions Among UK adults, self-reported diagnosed/suspected Covid-19 was not associated with vaping status. Half of current vapers changed their vaping consumption since Covid-19, with the majority reporting an increase, and a minority was motivated to quit due to Covid-19.
Does Nicotine Prevent Cytokine Storms in COVID-19?
- We discuss how his excessive use of nicotine replacement therapy may have contributed to his emerging unscathed from COVID-19. Nicotine, an α7-nACh receptor agonist, may boost the cholinergic anti-inflammatory pathway and hinder the uncontrolled overproduction of pro-inflammatory cytokines triggered by the SARS-CoV-2 virus, which is understood to be the main pathway to poor outcomes and death in severe COVID-19.
An exploratory non-randomized study of a 3-month electronic nicotine delivery system (ENDS) intervention with people accessing a homeless supported temporary accommodation service (STA) in Ireland accompanying helpful blog here My Study of Providing Vapes to Unhoused Smokers in Ireland
Nicotine delivery and user reactions to Juul EU (20 mg/ml) compared with Juul US (59 mg/ml), cigarettes and other e-cigarette products
- Juul EU delivers much less nicotine to users than Juul US, and also less than refillable EC products. It may thus have more limited potential to help smokers quit.